New Research Avenues Provide Hope for Metastatic Disease

 LIVE Symposium

Friday, May 24, 2024
11:30 AM - 2:30 PM Eastern Time

As research advances continue to improve therapeutic options in oncology, metastatic cancer research may hold the key to even bigger breakthroughs. From cellular motility to immune cell signaling, scientists seek to uncover the pathways that cancer cells take to metastasize. 

In this symposium brought to you by The Scientist, researchers will discuss cellular mechanisms of metastasis and recent discoveries about how advanced stage cancers move beyond their primary tissue of origin.

Symposium program

11:30 AM – Introduction

11:40 AM – The role of fluid flow in invasion and metastasis

Jennifer Munson, PhD 

12:10 PM – Leptomeningeal metastases overcome a hostile microenvironment

Adrienne Boire, MD, PhD 

12:40 PM – Who controls chemotactic gradients?

Robert Insall, PhD

1:10 PM – Targeting the dependence on PIK3C3-mTORC1 signaling in dormancy-prone breast cancer cells blunts metastasis initiation

Jean-François Côté, PhD

1:40 PM - Open panel Q&A session
Deanna MacNeil from The Scientist's Creative Services Team will be joined by the entire panel in an open question and answer session where presenters will address questions posed by the audience.

Jennifer Munson, PhD Associate Professor Fralin Biomedical Research Institute at Virginia Tech Carilion Department of Biomedical Engineering Virginia Tech

Adrienne Boire, MD, PhD  Neurologist and Neuro-Oncologist Memorial Sloan Kettering Cancer Center

Robert Insall, PhD Professor of Computational Cell Biology Department of Molecular and Cellular Biology University College London  School of Cancer Sciences, University of Glasgow

Jean-François Côté, PhD Full Research Professor Director, Cytoskeletal Organization and Cell Migration Research Montreal Clinical Research Institute University of Montreal